Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)David H Lawson, Sandra Lee, Fengmin Zhao, et al.
The EMBO Journal|September 27, 2008
DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activityKevin B Dong, Irina A Maksakova, Fabio Mohn, et al.
Leukemia & Lymphoma|December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Quantifying Social Determinants of Health for Disease Prediction: A Multi-Level Approach Using Healthy People 2030 and All of Us DataMicah R Hysong, Alisa K Manning, Michael Green, et al.
G3 (Bethesda, Md.)|October 19, 2014
Evidence for stabilizing selection on codon usage in chromosomal rearrangements of Drosophila pseudoobscuraZachary L Fuller, Gwilym D Haynes, Dianhui Zhu, et al.
The Journal of Pathology. Clinical Research|July 6, 2024
Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2Martin Köbel, Eun Young Kang, Sandra Lee, et al.
Cancer Immunology Research|May 20, 2017
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint BlockadeJun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, et al.
JCI Insight|September 22, 2017
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunityPearl Bakhru, Meng-Lei Zhu, Hsing-Hui Wang, et al.
Annals of Internal Medicine|November 11, 2024
Clinical Tools to Assess Functional Capacity During Risk Assessment Before Elective Noncardiac Surgery : A Scoping ReviewJulian F Daza, Tyler R Chesney, Juan F Morales, et al.
Pageof 13